OARK designed, developed, and built the first all-in-one operating table that is able to perform 11 specialty surgical operations and 3 general specialty surgical operations – all in one unit.
Evnia is one of the founders as well as a strategic shareholder and investor.
The first surgical unit that allows for multi-use operating rooms, designed for integration, modularity and mobility.
PerioVacX develops the first-ever therapeutic vaccine for Periodontitis, a global endemic affecting 50% of the adult population between 30-60 years old in the USA & Europe.
Evnia is one of the founders, a key shareholder, and an investor.
We are here to assist. Contact us by phone, email or via our Social Media channels (Twitter or LinkedIn).